The DOI matches its Crossref record; 141 of the 141 references it cites were found in a registry or an index.
Risk Factors and Preventions of Breast Cancer
Open accessAbstract
Breast cancer is the second leading cause of cancer deaths among women. The development of breast cancer is a multi-step process involving multiple cell types, and its prevention remains challenging in the world. Early diagnosis of breast cancer is one of the best approaches to prevent this disease. In some developed countries, the 5-year relative survival rate of breast cancer patients is above 80% due to early prevention. In the recent decade, great progress has been made in the understanding of breast cancer as well as in the development of preventative methods. The pathogenesis and tumor drug-resistant mechanisms are revealed by discovering breast cancer stem cells, and many genes are found related to breast cancer. Currently, people have more drug options for the chemoprevention of breast cancer, while biological prevention has been recently developed to improve patients' quality of life. In this review, we will summarize key studies of pathogenesis, related genes, risk factors and preventative methods on breast cancer over the past years. These findings represent a small step in the long fight against breast cancer.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Siegel, R. L., Miller, K. D., & Jemal, A. (2017) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21387 · Cited by 14,712
Prospective identification of tumorigenic breast cancer cells
Al-Hajj, M., Wicha, M. S., Benito-Hernandez, A., Morrison, S. J., & Clarke, M. F. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0530291100 · Cited by 10,370
International Journal of Environmental Research and Public Health
(2013) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph · Cited by 7,753
Macrophage Diversity Enhances Tumor Progression and Metastasis
Qian, B.-Z., & Pollard, J. W. (2010) · Cell · doi:10.1016/j.cell.2010.03.014 · Cited by 5,188
Tumor Metastasis: Molecular Insights and Evolving Paradigms
Valastyan, S., & Weinberg, R. A. (2011) · Cell · doi:10.1016/j.cell.2011.09.024 · Cited by 4,011
Breast cancer and hormone-replacement therapy in the Million Women Study
(2003) · The Lancet · doi:10.1016/s0140-6736(03)14065-2 · Cited by 2,993
American Cancer Society Guidelines for Breast Screening with MRI as an Adjunct to Mammography
Saslow, D., Boetes, C., Burke, W., Harms, S., Leach, M. O., Lehman, C. D., Morris, E., Pisano, E., Schnall, M., Sener, S., et al. (2007) · CA: A Cancer Journal for Clinicians · doi:10.3322/canjclin.57.2.75 · Cited by 2,637
Harbeck, N., & Gnant, M. (2017) · The Lancet · doi:10.1016/s0140-6736(16)31891-8 · Cited by 2,280
Vogel, C. L., Cobleigh, M. A., Tripathy, D., Gutheil, J. C., Harris, L. N., Fehrenbacher, L., Slamon, D. J., Murphy, M., Novotny, W. F., Burchmore, M., et al. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.2002.20.3.719 · Cited by 1,860
Meta-Analysis of BRCA1 and BRCA2 Penetrance
Chen, S., & Parmigiani, G. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2006.09.1066 · Cited by 1,802
RAS oncogenes: weaving a tumorigenic web
Pylayeva-Gupta, Y., Grabocka, E., & Bar-Sagi, D. (2011) · Nature Reviews Cancer · doi:10.1038/nrc3106 · Cited by 1,789
Cuzick, J., Sestak, I., Baum, M., Buzdar, A., Howell, A., Dowsett, M., & Forbes, J. F. (2010) · The Lancet Oncology · doi:10.1016/s1470-2045(10)70257-6 · Cited by 1,674
Structure of the extracellular region of HER2 alone and in complex with the Herceptin Fab
Cho, H.-S., Mason, K., Ramyar, K. X., Stanley, A. M., Gabelli, S. B., Denney, D. W., & Leahy, D. J. (2003) · Nature · doi:10.1038/nature01392 · Cited by 1,612
Marty, M., Cognetti, F., Maraninchi, D., Snyder, R., Mauriac, L., Tubiana-Hulin, M., Chan, S., Grimes, D., Antón, A., Lluch, A., et al. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.04.173 · Cited by 1,597
The benefits and harms of breast cancer screening: an independent review
(2012) · The Lancet · doi:10.1016/s0140-6736(12)61611-0 · Cited by 1,492
Adjuvant Pertuzumab and Trastuzumab in Early HER2-Positive Breast Cancer
von Minckwitz, G., Procter, M., de Azambuja, E., Zardavas, D., Benyunes, M., Viale, G., Suter, T., Arahmani, A., Rouchet, N., Clark, E., et al. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1703643 · Cited by 1,411
Breast cancer statistics, 2015: Convergence of incidence rates between black and white women
DeSantis, C. E., Fedewa, S. A., Goding Sauer, A., Kramer, J. L., Smith, R. A., & Jemal, A. (2016) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21320 · Cited by 1,252
Insights into ErbB signaling from the structure of the ErbB2-pertuzumab complex
Franklin, M. C., Carey, K. D., Vajdos, F. F., Leahy, D. J., de Vos, A. M., & Sliwkowski, M. X. (2004) · Cancer Cell · doi:10.1016/s1535-6108(04)00083-2 · Cited by 1,120
Collaborative Group on Hormonal Factors in Breast Cancer (2002) · British Journal of Cancer · doi:10.1038/sj.bjc.6600596 · Cited by 1,082
Effects of Raloxifene on Cardiovascular Events and Breast Cancer in Postmenopausal Women
Barrett-Connor, E., Mosca, L., Collins, P., Geiger, M. J., Grady, D., Kornitzer, M., McNabb, M. A., & Wenger, N. K. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa062462 · Cited by 1,048
Cameron, D., Piccart-Gebhart, M. J., Gelber, R. D., Procter, M., Goldhirsch, A., de Azambuja, E., Castro, G., Untch, M., Smith, I., Gianni, L., et al. (2017) · The Lancet · doi:10.1016/s0140-6736(16)32616-2 · Cited by 1,035
The Decrease in Breast-Cancer Incidence in 2003 in the United States
Ravdin, P. M., Cronin, K. A., Howlader, N., Berg, C. D., Chlebowski, R. T., Feuer, E. J., Edwards, B. K., & Berry, D. A. (2007) · New England Journal of Medicine · doi:10.1056/nejmsr070105 · Cited by 982
Exemestane for Breast-Cancer Prevention in Postmenopausal Women
Goss, P. E., Ingle, J. N., Alés-Martínez, J. E., Cheung, A. M., Chlebowski, R. T., Wactawski-Wende, J., McTiernan, A., Robbins, J., Johnson, K. C., Martin, L. W., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1103507 · Cited by 970
Overview of the main outcomes in breast-cancer prevention trials
Cuzick, J., Powles, T., Veronesi, U., Forbes, J., Edwards, R., Ashley, S., & Boyle, P. (2003) · The Lancet · doi:10.1016/s0140-6736(03)12342-2 · Cited by 965
(2008) · The Lancet Oncology · doi:10.1016/s1470-2045(07)70385-6 · Cited by 919
Ras in Cancer and Developmental Diseases
Fernandez-Medarde, A., & Santos, E. (2011) · Genes & Cancer · doi:10.1177/1947601911411084 · Cited by 897
Junttila, T. T., Akita, R. W., Parsons, K., Fields, C., Lewis Phillips, G. D., Friedman, L. S., Sampath, D., & Sliwkowski, M. X. (2009) · Cancer Cell · doi:10.1016/j.ccr.2009.03.020 · Cited by 829
Exploring the role of cancer stem cells in radioresistance
Baumann, M., Krause, M., & Hill, R. (2008) · Nature Reviews Cancer · doi:10.1038/nrc2419 · Cited by 815
Meta-Analysis of Breast Cancer Outcomes in Adjuvant Trials of Aromatase Inhibitors Versus Tamoxifen
Dowsett, M., Cuzick, J., Ingle, J., Coates, A., Forbes, J., Bliss, J., Buyse, M., Baum, M., Buzdar, A., Colleoni, M., et al. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.23.1274 · Cited by 813
Molyneux, G., Geyer, F. C., Magnay, F.-A., McCarthy, A., Kendrick, H., Natrajan, R., MacKay, A., Grigoriadis, A., Tutt, A., Ashworth, A., et al. (2010) · Cell Stem Cell · doi:10.1016/j.stem.2010.07.010 · Cited by 794
Transforming genes of carcinomas and neuroblastomas introduced into mouse fibroblasts
Shih, C., Padhy, L. C., Murray, M., & Weinberg, R. A. (1981) · Nature · doi:10.1038/290261a0 · Cited by 791
Gucalp, A., Tolaney, S., Isakoff, S. J., Ingle, J. N., Liu, M. C., Carey, L. A., Blackwell, K., Rugo, H., Nabell, L., Forero, A., et al. (2013) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-12-3327 · Cited by 749
Breast cancer: origins and evolution
Polyak, K. (2007) · Journal of Clinical Investigation · doi:10.1172/jci33295 · Cited by 697
Trastuzumab: Updated Mechanisms of Action and Resistance in Breast Cancer
Vu, T., & Claret, F. X. (2012) · Frontiers in Oncology · doi:10.3389/fonc.2012.00062 · Cited by 606
The role of p53 in cancer drug resistance and targeted chemotherapy
Hientz, K., Mohr, A., Bhakta-Guha, D., & Efferth, T. (2017) · Oncotarget · doi:10.18632/oncotarget.13475 · Cited by 587
BRCA1: cell cycle checkpoint, genetic instability, DNA damage response and cancer evolution
Deng, C.-X. (2006) · Nucleic Acids Research · doi:10.1093/nar/gkl010 · Cited by 584
Breast Cancer Epidemiology and Risk Factors
ROJAS, K., & STUCKEY, A. (2016) · Clinical Obstetrics & Gynecology · doi:10.1097/grf.0000000000000239 · Cited by 576
Arnould, L., Gelly, M., Penault-Llorca, F., Benoit, L., Bonnetain, F., Migeon, C., Cabaret, V, Fermeaux, V, Bertheau, P., Garnier, J., et al. (2006) · British Journal of Cancer · doi:10.1038/sj.bjc.6602930 · Cited by 545
Prognostic and predictive value of PDL1 expression in breast cancer
Sabatier, R., Finetti, P., Mamessier, E., Adelaide, J., Chaffanet, M., Ali, H. R., Viens, P., Caldas, C., Birnbaum, D., & Bertucci, F. (2015) · Oncotarget · doi:10.18632/oncotarget.3216 · Cited by 508
Breast Cancer: Current Molecular Therapeutic Targets and New Players
Nagini, S. (2017) · Anti-Cancer Agents in Medicinal Chemistry · doi:10.2174/1871520616666160502122724 · Cited by 503
Cuzick, J., Sestak, I., Bonanni, B., Costantino, J. P., Cummings, S., DeCensi, A., Dowsett, M., Forbes, J. F., Ford, L., LaCroix, A. Z., et al. (2013) · The Lancet · doi:10.1016/s0140-6736(13)60140-3 · Cited by 495
Pisano, E. D., Hendrick, R. E., Yaffe, M. J., Baum, J. K., Acharyya, S., Cormack, J. B., Hanna, L. A., Conant, E. F., Fajardo, L. L., Bassett, L. W., et al. (2008) · Radiology · doi:10.1148/radiol.2461070200 · Cited by 464
ATM Mutations in Cancer: Therapeutic Implications
Choi, M., Kipps, T., & Kurzrock, R. (2016) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-15-0945 · Cited by 453
MRI for breast cancer screening, diagnosis, and treatment
Morrow, M., Waters, J., & Morris, E. (2011) · The Lancet · doi:10.1016/s0140-6736(11)61350-0 · Cited by 448
Approaches to prevention of epithelial cancer during the preneoplastic period.
Sporn, M. B. (1976) · PubMed · Cited by 445
Smith, R. A., Brooks, D., Cokkinides, V., Saslow, D., & Brawley, O. W. (2013) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21174 · Cited by 422
The stroma as a crucial target in rat mammary gland carcinogenesis
Maffini, M. V., Soto, A. M., Calabro, J. M., Ucci, A. A., & Sonnenschein, C. (2004) · Journal of Cell Science · doi:10.1242/jcs.01000 · Cited by 416
Regan, M. M., Neven, P., Giobbie-Hurder, A., Goldhirsch, A., Ejlertsen, B., Mauriac, L., Forbes, J. F., Smith, I., Láng, I., Wardley, A., et al. (2011) · The Lancet Oncology · doi:10.1016/s1470-2045(11)70270-4 · Cited by 406
(2013) · The Lancet Oncology · doi:10.1016/s1470-2045(13)70301-2 · Cited by 399
Paluch-Shimon, S., Cardoso, F., Sessa, C., Balmana, J., Cardoso, M. J., Gilbert, F., & Senkus, E. (2016) · Annals of Oncology · doi:10.1093/annonc/mdw327 · Cited by 399
Mutational Profile of Metastatic Breast Cancers: A Retrospective Analysis
Lefebvre, C., Bachelot, T., Filleron, T., Pedrero, M., Campone, M., Soria, J.-C., Massard, C., Lévy, C., Arnedos, M., Lacroix-Triki, M., et al. (2016) · PLOS Medicine · doi:10.1371/journal.pmed.1002201 · Cited by 394
Baselga, J., Gómez, P., Greil, R., Braga, S., Climent, M. A., Wardley, A. M., Kaufman, B., Stemmer, S. M., Pêgo, A., Chan, A., et al. (2013) · Journal of Clinical Oncology · doi:10.1200/jco.2012.46.2408 · Cited by 363
Clinical obstetrics and gynecology
Smith, C. V., Scott, J. C., & Rayburn, W. F. (1991) · McGraw-Hill, Health Professions Division, PreTest Series eBooks · Cited by 344
Genomic Characterization of Primary Invasive Lobular Breast Cancer
Desmedt, C., Zoppoli, G., Gundem, G., Pruneri, G., Larsimont, D., Fornili, M., Fumagalli, D., Brown, D., Rothé, F., Vincent, D., et al. (2016) · Journal of Clinical Oncology · doi:10.1200/jco.2015.64.0334 · Cited by 318
Family history and risk of breast cancer: an analysis accounting for family structure
Brewer, H. R., Jones, M. E., Schoemaker, M. J., Ashworth, A., & Swerdlow, A. J. (2017) · Breast Cancer Research and Treatment · doi:10.1007/s10549-017-4325-2 · Cited by 316
O'Shaughnessy, J., Schwartzberg, L., Danso, M. A., Miller, K. D., Rugo, H. S., Neubauer, M., Robert, N., Hellerstedt, B., Saleh, M., Richards, P., et al. (2014) · Journal of Clinical Oncology · doi:10.1200/jco.2014.55.2984 · Cited by 311
Role of ErbB Receptors in Cancer Cell Migration and Invasion
Appert-Collin, A., Hubert, P., Crémel, G., & Bennasroune, A. (2015) · Frontiers in Pharmacology · doi:10.3389/fphar.2015.00283 · Cited by 310
Cancer screening - United States, 2010.
(2012) · PubMed · Cited by 284
Physical Activity and Breast Cancer Prevention
Lynch, B. M., Neilson, H. K., & Friedenreich, C. M. (2010) · Recent Results in Cancer Research · doi:10.1007/978-3-642-04231-7_2 · Cited by 282
Cancer Screening — United States, 2010
Klabunde, C. N., Brown, M. L., Ballard-Barbash, R. R., White, M. C., Thompson, T., Plescia, M., & King, S. C. (2012) · University Libraries (University of Maryland) · doi:10.13016/8cdm-qenw · Cited by 282
Davis, N. M., Sokolosky, M., Stadelman, K., Abrams, S. L., Libra, M., Candido, S., Nicoletti, F., Polesel, J., Maestro, R., D’Assoro, A., et al. (2014) · Oncotarget · doi:10.18632/oncotarget.2209 · Cited by 250
Beyond Mammography: New Frontiers in Breast Cancer Screening
Drukteinis, J. S., Mooney, B. P., Flowers, C. I., & Gatenby, R. A. (2013) · The American Journal of Medicine · doi:10.1016/j.amjmed.2012.11.025 · Cited by 242
Anti-Cancer Agents in Medicinal Chemistry
(2019) · Anti-Cancer Agents in Medicinal Chemistry · doi:10.2174/acamc-18715206-578 · Cited by 239
Patient Decisions About Breast Cancer Chemoprevention: A Systematic Review and Meta-Analysis
Ropka, M. E., Keim, J., & Philbrick, J. T. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.27.8077 · Cited by 230
BRCA in breast cancer: ESMO Clinical Practice Guidelines
Balmaña, J., Díez, O., Rubio, I. T., & Cardoso, F. (2011) · Annals of Oncology · doi:10.1093/annonc/mdr373 · Cited by 230
Breast Cancer: Major Risk Factors and Recent Developments in Treatment
Majeed, W., Aslam, B., Javed, I., Khaliq, T., Muhammad, F., Ali, A., & Raza, A. (2014) · Asian Pacific Journal of Cancer Prevention · doi:10.7314/apjcp.2014.15.8.3353 · Cited by 229
Boccardo, F., Rubagotti, A., Guglielmini, P., Fini, A., Paladini, G., Mesiti, M., Rinaldini, M., Scali, S., Porpiglia, M., Benedetto, C., et al. (2006) · Annals of Oncology · doi:10.1093/annonc/mdl941 · Cited by 222
Trastuzumab-containing regimens for metastatic breast cancer
Balduzzi, S., Mantarro, S., Guarneri, V., Tagliabue, L., Pistotti, V., Moja, L., & D'Amico, R. (2014) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd006242.pub2 · Cited by 218
Estrogen Effects on the Mammary Gland in Early and Late Life and Breast Cancer Risk
Dall, G. V., & Britt, K. L. (2017) · Frontiers in Oncology · doi:10.3389/fonc.2017.00110 · Cited by 216
Hegan, D. C., Lu, Y., Stachelek, G. C., Crosby, M. E., Bindra, R. S., & Glazer, P. M. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0904783107 · Cited by 209
BRCA in breast cancer: ESMO Clinical Practice Guidelines
Balmaña, J., Diez, O., Rubio, I., & Castiglione, M. (2010) · Annals of Oncology · doi:10.1093/annonc/mdq161 · Cited by 205
Triple Negative Breast Cancer – An Overview
Akshata Desai, K. A. (2012) · Hereditary Genetics · doi:10.4172/2161-1041.s2-001 · Cited by 200
Basho, R. K., Gilcrease, M., Murthy, R. K., Helgason, T., Karp, D. D., Meric-Bernstam, F., Hess, K. R., Herbrich, S. M., Valero, V., Albarracin, C., et al. (2017) · JAMA Oncology · doi:10.1001/jamaoncol.2016.5281 · Cited by 188
MYC—Master Regulator of the Cancer Epigenome and Transcriptome
Poole, C. J., & Van Riggelen, J. (2017) · Genes · doi:10.3390/genes8050142 · Cited by 183
Hormone replacement therapy and the risk of breast cancer
Narod, S. A. (2011) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2011.110 · Cited by 178
Targeting the Phosphatidylinositol 3-Kinase Signaling Pathway in Breast Cancer
Hernandez-Aya, L. F., & Gonzalez-Angulo, A. M. (2011) · The Oncologist · doi:10.1634/theoncologist.2010-0402 · Cited by 177
Dysregulation of macrophage polarization is associated with the metastatic process in osteosarcoma
Dumars, C., Ngyuen, J.-M., Gaultier, A., Lanel, R., Corradini, N., Gouin, F., Heymann, D., & Heymann, M.-F. (2016) · Oncotarget · doi:10.18632/oncotarget.13055 · Cited by 174
Valenti, G., Quinn, H. M., Heynen, G. J. J. E., Lan, L., Holland, J. D., Vogel, R., Wulf-Goldenberg, A., & Birchmeier, W. (2017) · Cancer Research · doi:10.1158/0008-5472.can-15-3490 · Cited by 171
Bane, A. L., Beck, J. C., Bleiweiss, I., Buys, S. S., Catalano, E., Daly, M. B., Giles, G., Godwin, A. K., Hibshoosh, H., Hopper, J. L., et al. (2007) · American Journal of Surgical Pathology · doi:10.1097/01.pas.0000213351.49767.0f · Cited by 170
Jung, S., Wang, M., Anderson, K., Baglietto, L., Bergkvist, L., Bernstein, L., van den Brandt, P. A., Brinton, L., Buring, J. E., Heather Eliassen, A., et al. (2016) · International Journal of Epidemiology · doi:10.1093/ije/dyv156 · Cited by 167
The paradoxical functions of EGFR during breast cancer progression
Ali, R., & Wendt, M. K. (2017) · Signal Transduction and Targeted Therapy · doi:10.1038/sigtrans.2016.42 · Cited by 167
MYC in breast tumor progression
Chen, Y., & Olopade, O. I. (2008) · Expert Review of Anticancer Therapy · doi:10.1586/14737140.8.10.1689 · Cited by 164
Dynamic interactions between the promoter and terminator regions of the mammalian BRCA1 gene
Tan‐Wong, S. M., French, J. D., Proudfoot, N. J., & Brown, M. A. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0801048105 · Cited by 159
Hormone replacement therapy after breast cancer: 10 year follow up of the Stockholm randomised trial
Fahlén, M., Fornander, T., Johansson, H., Johansson, U., Rutqvist, L.-E., Wilking, N., & von Schoultz, E. (2013) · European Journal of Cancer · doi:10.1016/j.ejca.2012.07.003 · Cited by 158
Hedgehog signalling in breast cancer
Kasper, M., Jaks, V., Fiaschi, M., & Toftgård, R. (2009) · Carcinogenesis · doi:10.1093/carcin/bgp048 · Cited by 155
HER2-targeted therapy in breast cancer. Monoclonal antibodies and tyrosine kinase inhibitors
Nielsen, D. L., Andersson, M., & Kamby, C. (2008) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2008.09.003 · Cited by 154
Zhang, D., LaFortune, T. A., Krishnamurthy, S., Esteva, F. J., Cristofanilli, M., Liu, P., Lucci, A., Singh, B., Hung, M., Hortobágyi, G. N., et al. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-09-0951 · Cited by 144
Triple negative breast cancer: shedding light onto the role of pi3k/akt/mtor pathway
Massihnia, D., Galvano, A., Fanale, D., Perez, A., Castiglia, M., Incorvaia, L., Listì, A., Rizzo, S., Cicero, G., Bazan, V., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.10858 · Cited by 143
Active cigarette smoking and risk of breast cancer
Catsburg, C., Miller, A. B., & Rohan, T. E. (2014) · International Journal of Cancer · doi:10.1002/ijc.29266 · Cited by 138
Carcinogenesis explained within the context of a theory of organisms
Sonnenschein, C., & Soto, A. M. (2016) · Progress in Biophysics and Molecular Biology · doi:10.1016/j.pbiomolbio.2016.07.004 · Cited by 137
miR-600 Acts as a Bimodal Switch that Regulates Breast Cancer Stem Cell Fate through WNT Signaling
Helou, R. E., Pinna, G., Cabaud, O., Wicinski, J., Bhajun, R., Guyon, L., Rioualen, C., Finetti, P., Gros, A., Mari, B. P., et al. (2017) · Cell Reports · doi:10.1016/j.celrep.2017.02.016 · Cited by 136
Green, A. R., Aleskandarany, M. A., Agarwal, D., Elsheikh, S. E., Nolan, C. C., Diez, M., Macmillan, R. D., Ball, G., Caldas, C., Madhusudan, S., et al. (2016) · British Journal of Cancer · doi:10.1038/bjc.2016.46 · Cited by 135
Bliss, J. M., Kilburn, L., Coleman, R. E., Forbes, J., Coates, A. S., Jones, S. E., Jassem, J., Delozier, T., ANDERSEN, J. E., Paridaens, R., et al. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2010.33.7899 · Cited by 130
A Myc Activity Signature Predicts Poor Clinical Outcomes in Myc-Associated Cancers
Jung, M., Russell, A. J., Liu, B., George, J., Liu, P. Y., Liu, T., DeFazio, A., Bowtell, D. D. L., Oberthuer, A., London, W. B., et al. (2016) · Cancer Research · doi:10.1158/0008-5472.can-15-2906 · Cited by 129
Berardi, R., Morgese, F., Onofri, A., Mazzanti, P., Pistelli, M., Ballatore, Z., Savini, A., Lisa, M. D., Caramanti, M., Rinaldi, S., et al. (2013) · Clinical and Translational Medicine · doi:10.1186/2001-1326-2-8 · Cited by 122
Sgroi, D. C. (2009) · Annual Review of Pathology Mechanisms of Disease · doi:10.1146/annurev.pathol.4.110807.092306 · Cited by 116
Aromatase inhibition 2013: clinical state of the art and questions that remain to be solved
Lønning, P. E., & Eikesdal, H. P. (2013) · Endocrine Related Cancer · doi:10.1530/erc-13-0099 · Cited by 112
miRNAs and Other Epigenetic Changes as Biomarkers in Triple Negative Breast Cancer
Mathe, A., Scott, R. J., & Avery‐Kiejda, K. A. (2015) · International Journal of Molecular Sciences · doi:10.3390/ijms161226090 · Cited by 111
Loibl, S., Jackisch, C., Schneeweiß, A., Schmatloch, S., Aktas, B., Denkert, C., Wiebringhaus, H., Kümmel, S., Warm, M. R., Paepke, S., et al. (2016) · Annals of Oncology · doi:10.1093/annonc/mdw610 · Cited by 110
Ductal Carcinoma in Situ of the Breasts: Review of MR Imaging Features
Greenwood, H. I., Heller, S. L., Kim, S., Sigmund, E. E., Shaylor, S. D., & Moy, L. P. (2013) · Radiographics · doi:10.1148/rg.336125055 · Cited by 109
Dubsky, P. C., Jakesz, R., Mlineritsch, B., Pöstlberger, S., Samonigg, H., Kwasny, W., Tausch, C., Stöger, H., Haider, K., Fitzal, F., et al. (2012) · Journal of Clinical Oncology · doi:10.1200/jco.2011.36.8993 · Cited by 108
Recent insights into cigarette smoking as a lifestyle risk factor for breast cancer
Kispert, S. E., & McHowat, J. (2017) · Breast Cancer Targets and Therapy · doi:10.2147/bctt.s129746 · Cited by 107
Basse, C., & Arock, M. (2014) · International Journal of Cancer · doi:10.1002/ijc.29347 · Cited by 105
BMI1 cooperates with H-RAS to induce an aggressive breast cancer phenotype with brain metastases
Hoenerhoff, M. J., Chu, I. M., Barkan, D., Liu, Z., Datta, S., Dimri, G. P., & Green, J. E. (2009) · Oncogene · doi:10.1038/onc.2009.165 · Cited by 104
Pooled analysis of active cigarette smoking and invasive breast cancer risk in 14 cohort studies
Gaudet, M. M., Carter, B. D., Brinton, L. A., Falk, R. T., Gram, I. T., Luo, J., Milne, R. L., Nyante, S. J., Weiderpass, E., Freeman, L. E. B., et al. (2016) · International Journal of Epidemiology · doi:10.1093/ije/dyw288 · Cited by 99
BRCA2 regulates DMC1-mediated recombination through the BRC repeats
Martinez, J. S., Nicolai, C. V., Kim, T., Ehlén, Å., Mazin, A. V., Kowalczykowski, S. C., & Carreira, A. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1601691113 · Cited by 96
The Cellular Origin and Evolution of Breast CancerPreprint
Zhang, M., Lee, A. V., & Rosen, J. M. (2017) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a027128 · Cited by 92
TP53 Status and Response to Treatment in Breast Cancers
Varna, M., Bousquet, G., Plassa, L., Bertheau, P., & Janin, A. (2011) · BioMed Research International · doi:10.1155/2011/284584 · Cited by 87
Dietary Fat in Breast Cancer Survival
Makarem, N., Chandran, U., Bandera, E. V., & Parekh, N. (2013) · Annual Review of Nutrition · doi:10.1146/annurev-nutr-112912-095300 · Cited by 85
Mouse models of BRCA1 and their application to breast cancer research
Dine, J. L., & Deng, C. (2012) · Cancer and Metastasis Reviews · doi:10.1007/s10555-012-9403-7 · Cited by 82
Bethea, T. N., Rosenberg, L. A., Hong, C., Troester, M. A., Lunetta, K. L., Bandera, E. V., Schedin, P. S., Kolonel, L. N., Olshan, A. F., Ambrosone, C. B., et al. (2015) · Breast Cancer Research · doi:10.1186/s13058-015-0535-x · Cited by 76
Breast cancer stem cells: Obstacles to therapy
Smalley, M. J., Piggott, L., & Clarkson, R. W. E. (2012) · Cancer Letters · doi:10.1016/j.canlet.2012.04.023 · Cited by 76
Triple Negative Breast Cancer – Overview
Garbino, C. (2012) · Journal of the Senologic International Society · doi:10.7170/jsis.v1i2.21 · Cited by 74
Emerging therapies for breast cancer
Hu, X., Huang, W., & Fan, M. (2017) · Journal of Hematology & Oncology · doi:10.1186/s13045-017-0466-3 · Cited by 72
ErbB-2 nuclear function in breast cancer growth, metastasis and resistance to therapy
Elizalde, P. V., Russo, R. I. C., Chervo, M. F., & Schillaci, R. (2016) · Endocrine Related Cancer · doi:10.1530/erc-16-0360 · Cited by 71
Risk factors and epidemiology of breast cancer
Washbrook, E. (2006) · Women s Health Medicine · doi:10.1383/wohm.2006.3.1.8 · Cited by 65
Architectural plasticity of human BRCA2–RAD51 complexes in DNA break repair
Sánchez, H., Paul, M. W., Grosbart, M., van Rossum-Fikkert, S. E., Lebbink, J. H. G., Kanaar, R., Houtsmuller, A. B., & Wyman, C. (2017) · Nucleic Acids Research · doi:10.1093/nar/gkx084 · Cited by 59
Reproductive and hormonal risk factors of breast cancer: a historical perspective
Horn, J., & VATTEN, L. J. (2017) · International Journal of Women s Health · doi:10.2147/ijwh.s129017 · Cited by 58
Soroush, A., Farshchian, N., Komasi, S., et al. (2016) · Journal of Cancer Prevention · doi:10.15430/jcp.2016.21.4.294 · Cited by 55
Wang, J., Song, C., Tang, H., Zhang, C., Tang, J., Li, X., Chen, B., & Xie, X. (2017) · Breast Cancer Research · doi:10.1186/s13058-017-0865-y · Cited by 55
Alanazi, I. O., & Khan, Z. (2016) · Asian Pacific Journal of Cancer Prevention · doi:10.7314/apjcp.2016.17.2.445 · Cited by 53
Cheng, L., Zhou, Z., Flesken‐Nikitin, A., Toshkov, I., Wang, W., Camps, J., Ried, T., & Nikitin, A. Y. (2010) · Oncogene · doi:10.1038/onc.2010.300 · Cited by 52
Effects of Raloxifene on Cardiovascular Events and Breast Cancer in Postmenopausal Women
Barrett‐Connor, E., Mosca, L. J., Collins, P. D., Geiger, M. J., Grady, D. G., Kornitzer, M., McNabb, M. A., & WENGER, N. K. (2006) · Obstetrical & Gynecological Survey · doi:10.1097/01.ogx.0000248825.32323.b3 · Cited by 51
Is androgen receptor targeting an emerging treatment strategy for triple negative breast cancer?
Anestis, A., Karamouzis, M. V., Dalagiorgou, G., & Papavassiliou, A. G. (2015) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2015.04.009 · Cited by 49
Loibl, S., Darb‐Esfahani, S., Huober, J., Klimowicz, A. C., Furlanetto, J., Lederer, B., Hartmann, A., Eidtmann, H., Pfitzner, B. M., Fasching, P. A., et al. (2016) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-15-0965 · Cited by 49
Mutations of the Epidermal Growth Factor Receptor Gene in Triple-Negative Breast Cancer
Kim, A., Jang, M. H., Lee, S. J., & Bae, Y. K. (2017) · Journal of Breast Cancer · doi:10.4048/jbc.2017.20.2.150 · Cited by 48
Aberrant Expression of Cyclin D1 in Cancer
Inoue, K., & Fry, E. A. (2015) · Signal Transduction Insights · doi:10.4137/sti.s30306 · Cited by 46
Reproductive factors and the risk of breast cancer in old age: a Norwegian cohort study
Horn, J., Åsvold, B. O., Opdahl, S., Tretli, S., & VATTEN, L. J. (2013) · Breast Cancer Research and Treatment · doi:10.1007/s10549-013-2531-0 · Cited by 46
Rosato, V., Bosetti, C., Negri, E., Talamini, R., Maso, L. D., Malvezzi, M., Falcini, F., Montella, M., & Vecchia, C. L. (2013) · European Journal of Cancer Prevention · doi:10.1097/cej.0b013e3283639f7a · Cited by 39
Aromatase inhibitors in breast cancer
Hiscox, S., Davies, E., & Barrett-Lee, P. J. (2009) · Maturitas · doi:10.1016/j.maturitas.2009.05.008 · Cited by 38
Exemestane for Breast-Cancer Prevention in Postmenopausal Women
Litton, J. K. (2012) · Breast Diseases A Year Book Quarterly · doi:10.1016/j.breastdis.2012.06.008 · Cited by 37
Boccardo, F., Guglielmini, P., Bordonaro, R., Fini, A., Massidda, B., Porpiglia, M., Roagna, R., Serra, P., Orzalesi, L., Ucci, G., et al. (2013) · European Journal of Cancer · doi:10.1016/j.ejca.2012.12.025 · Cited by 36
Chemoprevention for breast cancer
Božović‐Spasojević, I., de Azambuja, E., McCaskill‐Stevens, W., Dinh, P., & Cardoso, F. (2011) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2011.07.005 · Cited by 34
1–2 Effects of Raloxifene on Cardiovascular Events and Breast Cancer in Postmenopausal Women
Bevers, T. B. (2007) · Breast Diseases A Year Book Quarterly · doi:10.1016/s1043-321x(07)80007-5 · Cited by 31
Cigarette Smoking and Risk of Breast Cancer in a New Zealand Multi-Ethnic Case-Control Study
McKenzie, F., Ellison‐Loschmann, L., Jeffreys, M., Firestone, R. T., Pearce, N. E., & Romieu, I. (2013) · PLoS ONE · doi:10.1371/journal.pone.0063132 · Cited by 30
Yang, Y., Guo, R., Tian, X., Zhang, Z., Zhang, P., Li, C., & Feng, Z. (2017) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2017.06.001 · Cited by 25
Shukla, G., Khera, H. K., Srivastava, A., et al. (2017) · Current Stem Cell Research & Therapy · doi:10.2174/1574888x11666161028143224 · Cited by 23
Yang, Y., Pan, W., Tang, X., Wu, S., & Sun, X. (2017) · Oncotarget · doi:10.18632/oncotarget.16466 · Cited by 16
RAS pathway biomarkers for breast cancer prognosis.
van Reesema, L. L. S., Lee, M. P., Zheleva, V. P., Winston, J. S., O'Connor, C. F., Perry, R. R., Hoefer, R. A., & Tang, A. (2016) · PubMed · Cited by 16
Xu, J., Wang, X., Li, J., Xu, L., & Su, Y. (2015) · Drug Design Development and Therapy · doi:10.2147/dddt.s89861 · Cited by 13
Aromatase Inhibitors For Breast Cancer
Mayhew, M. S. (2009) · The Journal for Nurse Practitioners · doi:10.1016/j.nurpra.2009.04.008 · Cited by 9
Cited by
Feng, Y., Spezia, M., Huang, S., Yuan, C., Zeng, Z., Zhang, L., Ji, X., Liu, W., Huang, B., Luo, W., et al. (2018) · Genes & Diseases · doi:10.1016/j.gendis.2018.05.001 · Cited by 1,486
[Retracted] Global Increase in Breast Cancer Incidence: Risk Factors and Preventive Measures
Kashyap, D., Pal, D., Sharma, R., Garg, V. K., Goel, N., Koundal, D., Zaguia, A., Koundal, S., & Belay, A. (2022) · BioMed Research International · doi:10.1155/2022/9605439 · Cited by 529
RetractedNutrition and Breast Cancer: A Literature Review on Prevention, Treatment and Recurrence
De Cicco, P., Catani, M. V., Gasperi, V., Sibilano, M., Quaglietta, M., & Savini, I. (2019) · Nutrients · doi:10.3390/nu11071514 · Cited by 403
A Basic Review on Estrogen Receptor Signaling Pathways in Breast Cancer
Clusan, L., Ferrière, F., Flouriot, G., & Pakdel, F. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24076834 · Cited by 382
Wu, Z., Xia, F., & Lin, R. (2024) · Journal of Hematology & Oncology · doi:10.1186/s13045-024-01640-8 · Cited by 365
Metadata
- Authors
- Sun, Y.-S., Zhao, Z., Yang, Z.-N., Xu, F., Lu, H.-J., Zhu, Z.-Y., Shi, W., Jiang, J., Yao, P.-P., & Zhu, H.-P.
- Venue
- International Journal of Biological Sciences
- Publisher
- Ivyspring International Publisher
- Published
- 2017
- Volume
- 13
- Issue
- 11
- Pages
- 1387-1397
- ISSN
- 1449-2288 (ISSN-L)
- OpenAlex
- W2770397194
- Cited by
- 2,003
- References
- 141
- FWCI
- 22.62
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.